NPI: 1053391730 · STANLEY, WI 54768 · Certified Registered Nurse Anesthetist · NPI assigned 01/19/2006
Authorized official YANG, JERRY controls 20+ related entities in our dataset. Read more
| Authorized Official | YANG, JERRY (SVP & CHEIF FINANCIAL OFFICER) |
| NPI Enumeration Date | 01/19/2006 |
Other providers sharing the same authorized official: YANG, JERRY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 10,690 | $541K |
| 2019 | 10,570 | $698K |
| 2020 | 8,921 | $609K |
| 2021 | 11,526 | $636K |
| 2022 | 11,311 | $711K |
| 2023 | 11,698 | $718K |
| 2024 | 12,410 | $893K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 2,948 | 2,199 | $601K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3,062 | 2,435 | $563K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3,105 | 1,993 | $542K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1,916 | 1,702 | $523K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 2,101 | 1,663 | $475K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3,580 | 3,163 | $468K |
| 96361 | Intravenous infusion, hydration; each additional hour | 662 | 529 | $353K |
| 99215 | Prolong outpt/office vis | 1,003 | 861 | $223K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1,403 | 1,268 | $169K |
| 70450 | Computed tomography, head or brain; without contrast material | 457 | 378 | $158K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 532 | 302 | $111K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1,014 | 930 | $106K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 463 | 387 | $105K |
| 80053 | Comprehensive metabolic panel | 5,163 | 4,123 | $38K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2,456 | 2,102 | $34K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6,688 | 5,228 | $33K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1,803 | 595 | $26K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 238 | 218 | $19K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,278 | 944 | $19K |
| 84443 | Thyroid stimulating hormone (TSH) | 1,418 | 1,278 | $18K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 477 | 331 | $18K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 646 | 559 | $17K |
| 80061 | Lipid panel | 1,323 | 1,232 | $16K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 919 | 807 | $16K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 315 | 278 | $15K |
| 99001 | 1,811 | 1,592 | $13K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 29 | 25 | $13K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 817 | 756 | $12K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 967 | 301 | $11K |
| 84484 | 2,334 | 1,594 | $11K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 843 | 776 | $8K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 586 | 205 | $7K |
| 71046 | Radiologic examination, chest; 2 views | 604 | 538 | $6K |
| 81001 | 2,493 | 2,137 | $5K | |
| 87802 | 369 | 341 | $5K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2,597 | 1,966 | $5K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 803 | 715 | $5K |
| 83690 | 844 | 699 | $5K | |
| 87070 | 606 | 557 | $5K | |
| 85610 | 1,280 | 996 | $4K | |
| 83605 | 804 | 653 | $3K | |
| 83880 | 257 | 181 | $3K | |
| 87081 | 263 | 241 | $3K | |
| 80306 | 195 | 166 | $2K | |
| 83735 | 684 | 581 | $2K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1,337 | 1,078 | $2K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 15 | 13 | $2K |
| 36415 | Collection of venous blood by venipuncture | 4,594 | 3,662 | $1K |
| 85379 | 219 | 189 | $978.83 | |
| 71045 | Radiologic examination, chest; single view | 1,099 | 918 | $750.20 |
| 86140 | 214 | 182 | $727.68 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 76 | 27 | $653.96 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 15 | 12 | $583.23 |
| 81003 | 234 | 199 | $550.83 | |
| 87077 | 74 | 64 | $528.37 | |
| 85730 | 212 | 193 | $499.99 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 26 | 23 | $402.88 |
| 82805 | 15 | 12 | $359.99 | |
| 82150 | 81 | 69 | $338.43 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 14 | 12 | $324.05 |
| 81025 | 29 | 28 | $264.84 | |
| 96375 | Therapeutic injection; each additional sequential IV push | 855 | 687 | $226.99 |
| 85027 | 45 | 40 | $196.86 | |
| 87420 | 16 | 14 | $191.81 | |
| 84153 | 12 | 12 | $143.02 | |
| 87088 | 32 | 28 | $142.12 | |
| 87040 | 22 | 12 | $63.96 | |
| 87186 | 14 | 12 | $63.48 | |
| 82550 | 35 | 28 | $54.97 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 806 | 618 | $29.08 |
| 94762 | 162 | 142 | $13.15 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 235 | 194 | $7.76 |
| J7030 | Infusion, normal saline solution , 1000 cc | 770 | 602 | $6.49 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 621 | 491 | $1.99 |
| A9270 | Non-covered item or service | 933 | 553 | $0.56 |
| J2704 | Injection, propofol, 10 mg | 68 | 56 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 26 | 24 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 32 | 27 | $0.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 15 | 14 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 17 | 12 | $0.00 |